Personalis Inc
NASDAQ:PSNL 3:59:58 PM EDT
| Market Cap (Intraday) | 1.01B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $23.27 |
| 50-Day MA | $29.24 |
| 200-Day MA | $27.73 |
Personalis, Inc. Stock, NASDAQ:PSNL
1330 O'Brien Drive, Menlo Park, California 94025
United States of America
Phone: +1.650.752.1300
Number of Employees: 182
Description
Personalis, Inc. engages in the provision of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in 2011 and is headquartered in Menlo Park, CA.